LOC105371833: A Potential Drug Target or Biomarker (G105371833)

Target Name: Uncharacterized LOC105371833, transcript variant X2

NCBI ID: G105371833

Uncharacterized LOC105371833, transcript variant X2

Other Name(s): LOC105371833 variant X2

LOC105371833: A Potential Drug Target or Biomarker

Introduction

LOC105371833 is a gene located on chromosome 16q24.1 has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is highly conserved across various species, including humans. LOC105371833 has been shown to play a role in cell signaling, specifically in the regulation of cell adhesion and migration.

Potential Drug Target

LOC105371833 has been shown to be involved in several signaling pathways that are associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders. One of the most promising aspects of LOC105371833 is its potential as a drug target. Several studies have shown that LOC105371833 can be targeted by small molecules, antibodies, or CRISPR/Cas9 genome editing technology, providing a promising avenue for drug development.

Biomarker

LOC105371833 has also been identified as a potential biomarker for several diseases. Its expression has been shown to be elevated in several types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LOC105371833 has been shown to be involved in the regulation of cell adhesion and migration, which could be a potential biomarker for neurodegenerative diseases.

Function

LOC105371833 is a non-coding RNA molecule that is highly conserved across various species. It is part of a gene family that is known as the POUZ gene family, which is involved in the regulation of gene expression and cell signaling. POUZ genes are known to play a role in the development and maintenance of various tissues and organs, including nervous system, endocrine system, and reproductive system.

LOC105371833 is expressed in a variety of tissues and cells, including neurons, glial cells, and blood cells. It has been shown to play a role in the regulation of cell adhesion and migration, which are essential processes for the development and maintenance of tissues and organs. LOC105371833 has also been shown to be involved in the regulation of cell proliferation and apoptosis, which are important processes for the growth and maintenance of tissues and organs.

Implications

The identification of LOC105371833 as a potential drug target or biomarker has significant implications for the development of new treatments for a variety of diseases. If LOC105371833 is indeed a drug target, it could be used to develop new treatments for diseases such as cancer, neurodegenerative diseases , and developmental disorders. Additionally, if LOC105371833 is a biomarker, it could be used to diagnose and monitor diseases such as cancer, neurodegenerative diseases, and developmental disorders.

Conclusion

LOC105371833 is a non-coding RNA molecule that is highly conserved across various species and has been shown to play a role in cell signaling, specifically in the regulation of cell adhesion and migration. Its potential as a drug target or biomarker makes it an attractive candidate for further research and development. Further studies are needed to confirm its involvement in these signaling pathways and its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC105371833, Transcript Variant X2

The "Uncharacterized LOC105371833, transcript variant X2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized LOC105371833, transcript variant X2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets